Loring Wolcott & Coolidge Fiduciary Advisors’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio GRX Stock Details GRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,770	Closed	-$17K	–	691
2018 Q1	$17K	Hold	1,770	–	–	﹤0.01%	550
2017 Q4	$18K	Hold	1,770	–	–	﹤0.01%	527
2017 Q3	$18K	Hold	1,770	–	–	﹤0.01%	516
2017 Q2	$19K	Hold	1,770	–	–	﹤0.01%	496
2017 Q1	$18K	Hold	1,770	–	–	﹤0.01%	501
2016 Q4	$17K	Hold	1,770	–	–	﹤0.01%	482
2016 Q3	$18K	Hold	1,770	–	–	﹤0.01%	487
2016 Q2	$19K	Sell	1,770 -1,240	-41%	-$12.8K	﹤0.01%	488
2016 Q1	$30K	Hold	3,010	–	–	﹤0.01%	447
2015 Q4	$31K	Hold	3,010	–	–	﹤0.01%	478
2015 Q3	$34K	Hold	3,010	–	–	﹤0.01%	455
2015 Q2	$34K	Hold	3,010	–	–	﹤0.01%	455
2015 Q1	$34K	Buy	+3,010	New	+$32.5K	﹤0.01%	472

Other funds holding GRX

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cornerstone Advisors Asheville, North Carolina $3.04B AUM 36.62% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TJHA

Thomas J. Herzfeld Advisors Miami Beach, Florida $294M AUM 2.62% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's GRX Position: Q2 2018 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Gabelli Healthcare & Wellness Trust (GRX) in Q2 2018, closing a stake of 1,770 shares — an estimated $17K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in GRX in Q1 2015 and held it in 13 quarters. The position peaked at $34K in Q3 2015. 67 funds tracked by Wall St. Rank hold GRX as of Q2 2018.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Gabelli Healthcare & Wellness Trust position as of Q2 2018 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 1,770 Gabelli Healthcare & Wellness Trust shares in Q2 2018, an estimated $17K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Gabelli Healthcare & Wellness Trust in Q1 2015 and held it in 13 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's Gabelli Healthcare & Wellness Trust position peaked at $34K in Q3 2015.
67 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q2 2018.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.